DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Mangalam Drugs And Organics Limited — Board Meeting Intimation

NSE 1 hr ago·5 Aug 2026, 12:50 pm

Mangalam Drug & Chem

Mangalam Drugs and Organics has announced that its board will meet on August 12, 2026, to review and approve the company's unaudited quarterly financial results for the period ending June 2026. This is a standard corporate procedure where the board evaluates the firm's performance over the last quarter before the figures are officially disclosed to the public.

For investors, this meeting is significant because it will reveal how the company performed during the first quarter of the financial year. The results will provide insights into the company's operational health, profitability, and cash flow, which are key factors for assessing its future growth prospects.

Investors should watch for the release of these results to gauge the company's current trajectory. Any positive or negative surprises in the earnings report could influence the stock's price movement in the coming days.